Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/216080 stock hub

KOSDAQ/216080 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/216080is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
240.7B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/216080
In the news

Latest news · KOSDAQ/216080

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/En/a
P25 12P50 23.1P75 39.5
ROE-10.8
P25 -17.1P50 0.7P75 8.5
ROIC2.2
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/216080 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
189
Groups with data
11
Currency
KRW
Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
265
Enterprise value
KRW 352.8B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Biotechnology
Isin
KR7216080002
Last refreshed
2026-05-10
Market cap
KRW 240.7B
Price
KRW 6,470
Price currency
KRW
Rev Per Employee
290,199,562.49x
Sector
Healthcare
Sic
2834
Symbol
kosdaq/216080
Website
https://www.jetema.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-2.74%
EV Earnings
-53.44x
EV/EBIT
108.55x
EV/EBITDA
29.88x
EV/FCF
65.41x
EV/Sales
4.59x
FCF yield
2.24%
P/B ratio
3.67x
P/S ratio
3.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
4.97%
EBITDA Margin
16.1%
FCF margin
7.01%
Gross margin
47.44%
Gross Profit
KRW 36.5B
Gross Profit Growth
10.43%
Gross Profit Growth Q
71.92%
Net Income
KRW -6.6B
Net Income Growth Q
-49.54%
Net Income Growth Years
0%
Pretax Margin
-10%
Profit Margin
-8.59%
Profit Per Employee
KRW -24.9M
ROA
1.11
ROCE
3.03
ROE
-10.8
ROIC
2.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr1y
-11.74%
Cagr3y
-13.93%
Cagr5y
-17.98%
EPS Growth Q
-39.08
EPS Growth Years
0
FCF Growth
133.31%
OCF Growth
197.39%
OCF Growth Q
-97.89%
Revenue Growth
12.23x
Revenue Growth Q
7.11x
Revenue Growth Quarters
3x
Revenue Growth Years
8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
KRW 0.36
Assets
KRW 209.1B
Cash
KRW 5.2B
Current Assets
KRW 31.3B
Current Liabilities
KRW 83.1B
Debt
KRW 117.2B
Debt EBITDA
KRW 9.46
Debt Equity
KRW 1.79
Debt FCF
KRW 21.72
Equity
KRW 65.6B
Interest Coverage
0.36
Liabilities
KRW 143.5B
Long Term Assets
KRW 177.8B
Long Term Liabilities
KRW 60.4B
Net Cash
KRW -111.9B
Net Cash By Market Cap
KRW -46.49
Net Debt EBITDA
KRW 9.04
Net Debt Equity
KRW 1.71
Net Debt FCF
KRW 20.75
Tangible Book Value
KRW 62.7B
Tangible Book Value Per Share
KRW 1,744
WACC
8.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.38
Inventory Turnover
2.24
Net Working Capital
KRW 9.6B
Quick ratio
0.13
Working Capital
KRW -51.8B
Working Capital Turnover
KRW -1.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
4.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-11.73%
200-day SMA
7,041
3Y total return
-36.26%
50-day SMA
7,902.4
50-day SMA vs 200-day SMA
50over200
5Y total return
-62.87%
All Time High
21,375
All Time High Change
-69.73%
All Time High Date
2021-06-28
All Time Low
2,100
All Time Low Change
208.1%
All Time Low Date
2020-03-19
ATR
429.2
Beta
0.77
Beta1y
0.53
Beta2y
0.44
Ch YTD
5.72
High
6,590
High52
11,280
High52 Date
2026-02-25
High52ch
-42.64%
Low
6,350
Low52
5,370
Low52 Date
2025-11-10
Low52ch
20.48%
Ma50ch
-18.13%
Price vs 200-day SMA
-8.11%
RSI
30.16
RSI Monthly
45.14
RSI Weekly
39.3
Sharpe ratio
-0.03x
Sortino ratio
0.06
Total Return
4.69%
Tr YTD
5.72
Tr1m
-10.14%
Tr1w
-7.44%
Tr3m
-33.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
KRW 3.8B
Operating Income Growth
-4.3
Operating margin
4.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
26,662,619%
Net Borrowing
-14,796,161,230
Shares Insiders
28.22%
Shares Institutions
0.18%
Shares Out
37,209,099
Shares Qo Q
0.35%
Shares Yo Y
-4.69%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
KRW 5.7B
Average Volume
430,272.55x
Bv Per Share
1,819
CAPEX
KRW -5.7B
Ch1m
-10.14
Ch1w
-7.44
Ch1y
-11.73
Ch3m
-33.23
Ch3y
-36.26
Ch5y
-62.87
Ch6m
19.82
Change
-0.31%
Change From Open
-0.61
Close
6,490
Days Gap
0.31
Depreciation Amortization
8,559,066,000
Dollar Volume
1,040,751,260
Earnings Date
2026-05-15
EBIT
KRW 3.8B
EBITDA
KRW 12.4B
EPS
KRW -184
F Score
5
FCF
KRW 5.4B
FCF EV Yield
1.53x
FCF Per Share
KRW 145
Financing CF
-14,764,529,700
Fiscal Year End
December
Founded
2,009
Income Tax
KRW -252.6M
Investing CF
-14,314,294,850
Is Primary Listing
1
Last Earnings Date
2026-02-09
Last Report Date
2025-12-31
Last Split Date
2025-01-03
Last Split Type
Forward
Ma150
7,232.3
Ma150ch
-10.54%
Ma20
7,111.5
Ma20ch
-9.02%
Net CF
-18,208,104,690
Next Earnings Date
2026-05-15
Open
6,510
P FCF Ratio
44.63
P OCF Ratio
21.78
Position In Range
50
Ppne
119,527,814,380
Price Date
2026-05-08
Price EBITDA
KRW 19.45
Ptbv Ratio
3.84
Relative Volume
0.37x
Revenue
76,902,884,060x
SBC By Revenue
-0.4x
Share Based Comp
-305,275,000
Tax By Revenue
-0.33x
Tr6m
19.82%
Volume
160,858
Z Score
0.96
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/216080 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/216080 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-11.7%
S&P 500 1Y: n/a
3Y total return
-36.3%
S&P 500 3Y: n/a
5Y total return
-62.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/216080?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.2%
Share of float held by funds and institutions
Insider ownership
+28.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-4.7%
Negative means the company is buying back shares.
Technical

KOSDAQ/216080 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
30.2
Neutral momentum band
Price vs 200-day MA
-8.1%
50/200-day relationship not available
Beta (5Y)
0.77
Less volatile than the market
Sharpe ratio
-0.03
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/216080

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/216080 stock rating?

kosdaq/216080 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/216080 analysis?

The full report lives at /stocks/kosdaq/216080/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/216080?

The latest report frames kosdaq/216080 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/216080 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.